US60039A - Improved medicated troches - Google Patents
Improved medicated troches Download PDFInfo
- Publication number
- US60039A US60039A US60039DA US60039A US 60039 A US60039 A US 60039A US 60039D A US60039D A US 60039DA US 60039 A US60039 A US 60039A
- Authority
- US
- United States
- Prior art keywords
- troches
- improved
- improved medicated
- medicated
- philadelphia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 241000219823 Medicago Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229940050962 powdered opium Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
UNITED STATES PATENT OFF E;
oAnE H.- NEEDLES, OF PHILADELPHIA, 'rENNsYLyANLA,
IMPROVED MEDlCATEIiTROCl-IES,
Specification formingpart of Ltters Patent o. 60,089,. a ate November 27, 185
To all whom at may concern:
Be it knownthat I, CALEB'H. NEEDLES of Philadelphia, in the county of Philadelphia, State of Pennsylvania, have invented a MedicatedTroche, composed of the following ingredients, and made as per annexed formula. v
I combine camphor, catecli-u,.Jan1aica gingen,- African capsicum, powdered opium, and the essential oilsflof peppermint and cloves. ,Work the same with amucila-ge of .tragacanth into consistence suitable to be-rolled in sheets-cutting these by means-of inoldsinto The process of manufacture (without heat) secures-thees'sential properties of eachdrng with no change in the characteristics of said ingredients. I t
' I do not confine myselffto the above proportions, but I regard them as the best; 'nor is, it necessary that everyindiyidnal. article should be used, for the materia medics will supply equivalents for some of, them, as is well known to the medical faci'rlty; nor is it p necessary that the several active principles embraced in my preparation be added inthe 'form given abo\'e, as it is the medical prop-f erties rather than thepeculiar' drugs which,
inflcom'bination, constitute myinvention.
Having thus described iny invention,'-what I claim, and desireto secure by Letters Patcut, is
The compound camphor trochs, prepared substantially as hereinst forth and described CALEB NEEDLES.
Witnesses:
Josnrn VY. WEBB,
CARL Faun.
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US60039A true US60039A (en) | 1866-11-27 |
Family
ID=2129578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US60039D Expired - Lifetime US60039A (en) | Improved medicated troches |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US60039A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4324785A (en) * | 1980-05-20 | 1982-04-13 | Emma S. Stevens | Foot powder |
| US5906825A (en) * | 1997-10-20 | 1999-05-25 | Magellan Companies, Inc. | Polymers containing antimicrobial agents and methods for making and using same |
-
0
- US US60039D patent/US60039A/en not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4324785A (en) * | 1980-05-20 | 1982-04-13 | Emma S. Stevens | Foot powder |
| US5906825A (en) * | 1997-10-20 | 1999-05-25 | Magellan Companies, Inc. | Polymers containing antimicrobial agents and methods for making and using same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12022552828A1 (en) | Substituted aminothiazoles as dgkzeta inhibitors for immune activation | |
| EP2862575B1 (en) | Application of piceatannol-3'-o-b-d-glucopyranoside in preparation of medicaments for improving microcirculation block | |
| KR101640958B1 (en) | Pharmaceutical solid preparation having active ingredients separated by boundary therein | |
| DE60319211T2 (en) | COMBINATION OF GLIVEC (STI571) WITH A CYCLINE-DEPENDENT KINASEIN HIBITOR, IN PARTICULAR FLAVOPIRIDOL, FOR THE TREATMENT OF CANCER | |
| US59756A (en) | Improved medical compound | |
| EP3782620B1 (en) | Pharmaceutical composition comprising 1,2-naphthoquinone derivative for use in preventing or treating acute myeloid or lymphoblastic leukemia | |
| US56075A (en) | Improved medicine for hog-cholera | |
| CA2554082A1 (en) | Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism | |
| US444601A (en) | Am able robidoux | |
| DE3247514C2 (en) | ||
| US61730A (en) | To all whom it mat concern | |
| DE1617286C (en) | Medicines based on 4-methyl-5- (2-chloroethyl) -thiazole | |
| KR102965629B1 (en) | Application of a cilostazol-containing composition in the manufacture of a drug for the treatment of cerebrovascular disease | |
| US81181A (en) | Improved medicine toe fevee and ague | |
| US54550A (en) | Improved medical compound | |
| US55342A (en) | Improved liniment | |
| US62717A (en) | John s | |
| DE874645C (en) | Foot pad | |
| US275472A (en) | Budolf doen | |
| US49015A (en) | Improved medicine for horses | |
| KR102875039B1 (en) | Pharmaceutical composition comprising of 1,2-naphothoquinone derivatives for preventing or treating solid tumor or hematologic cancer | |
| US55449A (en) | Improved medicine | |
| US57357A (en) | Improved medicine | |
| US259070A (en) | Medical compound for diphtheria | |
| US343660A (en) | Beenaed faeley |